63 results on '"Posey J"'
Search Results
2. Loss of Vascular EC-SOD Is Protective Against PH in the Sugen Hypoxia Model of Pulmonary Hypertension Through Changes in Mitochondrial Respiration Mediated by p-AMPK
3. Loss of Vascular EC-SOD Is Associated with Worse RV Hypertrophy and Decreased Mitochondrial Content in a Model of Pulmonary Hypertension
4. The Presence of Circulating Tumor DNA in Ovarian Cancer Patients After Platinum-Based Chemotherapy
5. Analytical performance of the resolution-HRD plasma assay used to identify mCRPC patients with biallelic disruption of DNA repair genes for treatment with niraparib
6. Ch. 5: Transportation. Climate Change Impacts in the United States: The Third National Climate Assessment
7. EMERGENCE OF BEDAQUILINE RESISTANCE AFTER COMPLETION OF BEDAQUILINE-BASED DRUGRESISTANT TB TREATMENT: A CASE STUDY FROM SOUTH AFRICA
8. WHOLE GENOME SEQUENCING SHEDS LIGHT ON THE TRANSMISSION DYNAMICS OF A MULTIDRUG RESISTANT MYCOBACTERIUM TUBERCULOSIS OUTBREAK OVER 23 YEARS IN A HIGH INCIDENCE SETTING
9. Detection of Apparent Cell-free M. tuberculosis DNA from Plasma
10. Sleep deprivation affects reactivity to positive but not negative stimuli
11. Unconventional Bench And Pilot Approaches For Chemical Adhesive Wastewater Treatment
12. Stereotactic Body Radiation Therapy Followed by Sorafenib Improves Survival Without Increasing Toxicity
13. Intensity Modulated Radiation Therapy for Anal Cancer: The UAB Experience
14. ChemInform Abstract: An Approach to the Design of Lightfast Disperse Dyes. Analogs of Disperse Yellow 42.
15. A phase I study evaluating the role of the anti-epidermal growth factor receptor (EGFR) antibody cetuximab as a radiosensitizer with chemoradiation for locally advanced pancreatic cancer
16. Early imaging and molecular response determinants in advanced pancreatic cancer.
17. A qualitative study of exceptional survivors of cancer
18. A phase II study of IMGN242 (huC242-DM4) in patients with CanAg-positive gastric or gastroesophageal (GE) junction cancer
19. Prognostic significance of VDR, DKK-1, and DKK-4 expression in colorectal cancer
20. 787 EFFECTS OF HEPATIC IMPAIRMENT ON THE PHARMACOKINETICS OF BRIVANIB IN A PHASE I, OPEN-LABEL, MULTIDOSE STUDY IN PATIENTS WITH HEPATOCELLULAR CARCINOMA AND OTHER SOLID TUMORS
21. A phase I study of CS-1008 (humanized monoclonal antibody targeting death receptor 5 or DR5), administered weekly to patients with advanced solid tumors or lymphomas
22. Intensity-modulated radiation therapy (IMRT) with concurrent chemotherapy for anal cancers: Acute toxicity profile and avoidance of a treatment break
23. The 2-13C-5-fluorouracil breath test (FUBT) as a novel, rapid method for assessment of dihydropyrimidine dehydrogenase (DPD) activity in cancer patients: Initial characterization and comparison to the 2-13C-uracil breath test (UraBT)
24. A phase I trial of RX-0201 (AKT anti-sense) in patients with an advanced cancer
25. A fast method of deriving the Kirchhoff formula for moving surfaces
26. Phase I study of RX-0201 in patients with advanced or metastatic solid tumors
27. Phenotypic expression of Bax is a predictive marker of 5-fluorouracil treatment in colorectal cancer
28. Efficacy of gemcitabine/irinotecan in female patients ≤ 56 yrs with metastatic pancreatic cancer
29. Erlotinib as a Radiosensitizer for Patients with Esophageal Cancer
30. Results of a phase 2/3 open-label, randomized trial of T138067 versus doxorubicin (DOX) in chemotherapy-naïve, unresectable hepatocellular carcinoma (HCC)
31. A phase 2 study to evaluate the efficacy and safety of SU11248 in patients (pts) with unresectable neuroendocrine tumors (NETs)
32. PXR and the regulation of apoA1 and HDL-cholesterol in rodents
33. A phase II study of irinotecan and docetaxel with concurrent radiotherapy as preoperative treatment in resectable esophageal cancer
34. UAB's experience with concurrent capecitabine (CAP) and radiotherapy (RT) in Pts with resected (RES) or locally advanced (LA) pancreatic cancer (Pan Ca)
35. A phase II study of irinotecan and docetaxel with concurrent radiotherapy as preoperative treatment in resectable esophageal cancer
36. UAB's experience with concurrent capecitabine (CAP) and radiotherapy (RT) in Pts with resected (RES) or locally advanced (LA) pancreatic cancer (Pan Ca)
37. Bladder tumor markers for monitoring recurrence and screening comparison of hyaluronic acid–hyaluronidase and BTA‐Stat tests
38. Dissolution of HFIR control plates
39. CHEMICAL DECOMPOSITION OF SOLUTIONS OF AMMONIUM NITRATE
40. THE VAPOR PRESSURE OF URANIUM PENTAFLUORIDE IN THE SOLID AND LIQUID STATES
41. CONSEQUENCES OF INTERNAL HEAT FLOW IN RADIOISOTOPE HEAT SOURCES.
42. VISCOSITY OF GASEOUS ANHYDROUS HYDROGEN FLUORIDE
43. AN AIR-PULSED LABORATORY MIXER-SETTLER
44. Pilot trial of MDX-H210 and GM-CSF for patients with advanced erbB-2 positive malignancies
45. PILOT TRIAL OF MDX-H210 AND GM-CSF FOR PATIENTS WITH ADVANCED ERBB-2 POSITIVE MALIGNANCIES
46. Genetic Factors for the Development of Alzheimer Disease in the Cherokee Indian
47. ChemInform Abstract: Purification Procedures for Synthetic Dyes. Part 4. Flash Chromatography.
48. A thermal microstructure measurement system (TMMS) to support high‐frequency acoustic experiments
49. The validity of selected surrogate measures of human resource value: A field study
50. Oil accumulation and production characteristics in major Texas oil reservoirs
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.